Technical Data
V2100-13E
Varicella Zoster Virus, IE62 (VZV)
Description:
VZV is a member of the human herpes virus family which causes two distinct clinical manifestations: childhood chickenpox (Varicella) and shingles (Zoster). Varicella is the outcome of the primary infection with VZV, whereas, Zoster is the result of VZV reactivation from latently infected sensory ganglia which occurs predominantly in aging and immuno-suppressed individuals.

Applications:
Suitable for use in Immunofluorescence and Immunocytochemistry. Other applications not tested.

Recommended Dilution:
Immunofluorescence: 1:10-1:50
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
TypeIsotypeCloneGrade
MabIgG15E452Affinity Purified
SizeStorageShippingSourceHost
1ml-20CBlue IceMouse
Concentration:
~0.1mg/ml
Immunogen:
Purity:
Purified by Protein A affinity chromatography.
Form
Supplied as a liquid in PBS, pH 7.2, 0.1% sodium azide. No stabilizing proteins have been added.
Specificity:
Recognizes an Immediate Early protein (gene 62; 180kD) of Varicella Zoster Virus.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.